Real-time enrollment status for this membranous nephropathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:31 PM UTC
| NCT Number | NCT03949855 |
| Recruiting Status | Recruiting |
| Condition | Membranous Nephropathy |
| Phase | PHASE2 |
| Target Enrollment | 58 participants |
| Active Locations | 20 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT03949855 is currently recruiting participants. This phase2 study for membranous nephropathy is actively seeking new participants at 20 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03949855 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03949855 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.